RxDoctor Payments DataLook up a doctor →

Viju Vijaysadan, MD

Internal Medicine · Kinnelon, NJNPI 1538110754

Payments from drug & device makers

$324,948in general payments, 2019–2025

Across 1,440 payments — averaging $225.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$295K
  • Mannkind Corporation$11K
  • Intuity Medical Inc$5K
  • Medtronic$3K
  • Amgen$1K
  • Bayer$1K
  • plus $9K from 54 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AstraZeneca515$295,071
Mannkind Corporation163$10,582
Intuity Medical Inc25$5,392
Medtronic37$2,783
Amgen(2 entities)84$1,278
Bayer72$1,182
Novo Nordisk58$1,161
GSK48$867
Axsome Therapeutics, Inc.62$785
Optinose US, Inc.20$385
Pfizer26$368
Merck23$346
Lilly USA, LLC23$319
Sanofi-aventis U.S. LLC22$319
Idorsia Pharmaceuticals US Inc22$318
Collegium Pharmaceutical, Inc.24$313
Exact Sciences14$266
Arbor Pharmaceuticals, Inc.19$261
Boehringer Ingelheim17$248
Novartis21$240
Abbott11$231
Cumberland Pharmaceuticals, Inc.10$186
Mylan Specialty L.p.9$144
Amarin Pharma, Inc.10$141
Viatris Specialty LLC8$139
Corcept Therapeutics8$129
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC4$128
Intra-sana Laboratories2$114
Ardelyx, Inc.5$82
Indivior Inc.5$76
Biohaven Pharmaceuticals, Inc.4$73
Dexcom, Inc.4$69
Kaleo, Inc.5$67
Azurity Pharmaceuticals, Inc.4$66
AbbVie(2 entities)4$64
Xeris Pharmaceuticals, Inc.4$62
Johnson & Johnson4$61
Almatica Pharma LLC4$54
Vifor Pharma, Inc.4$53
Ultragenyx Pharmaceutical Inc.3$46
Althera Pharmaceuticals LLC5$45
Kowa Pharmaceuticals America, Inc.3$44
ARS Pharmaceuticals Operations, Inc.2$39
E.r. Squibb & Sons, L.L.C.2$33
Halozyme Inc2$32
Lundbeck LLC2$30
Antares Pharma, Inc.2$29
Nestle Healthcare Nutrition Inc.2$29
Biohaven Pharmaceutical Holding Company Ltd.2$28
Advanced Respiratory, Inc1$20
Cequr Corporation1$19
Ferring Pharmaceuticals Inc.1$19
Aimmune Therapeutics, Inc.1$17
Evoke Pharma, Inc.1$17
Shire North American Group Inc1$15
Baxter Healthcare1$15
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)1$14
Genentech USA, Inc.1$14
Sanofi Pasteur Inc.1$12
Vistapharm, Inc.1$12

How this compares

$324,948 in reported general payments places this provider in the 95th percentile of 4,032 internal medicine providers in New Jersey.

See all internal medicine providers in New Jersey →

Medicare billing

Part B allowed, 2024
$636,689
Medicare patients
286
Services billed
19,264

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other internal medicine in Kinnelon

See the full list for New Jersey →

Where these figures come from

Is this you, or does something look wrong? →